Sorrento Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q2 2023

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Sorrento Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q2 2023.
  • Sorrento Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2023 was 551M shares, a 26.3% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 551M +115M +26.3% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 551M +176M +46.9% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 523M +208M +66.2% Dec 31, 2022 10-Q 2023-08-14
Q3 2022 468M +165M +54.3% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 436M +138M +46.5% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 375M +89.5M +31.3% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 315M +39.3M +14.3% Dec 31, 2021 10-K 2023-03-16
Q3 2021 303M +41.7M +15.9% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 298M +66.1M +28.5% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 286M +81.1M +39.6% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 275M +107M +64.1% Dec 31, 2020 10-K 2022-03-11
Q3 2020 262M +131M +99.8% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 232M +109M +89% Jun 30, 2020 10-Q 2020-08-04
Q1 2020 205M +82.3M +67.2% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 168M +45.5M +37.2% Dec 31, 2019 10-K 2021-02-19
Q3 2019 131M +12.1M +10.2% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 123M +6.4M +5.51% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 122M +31.3M +34.4% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 122M +39.4M +47.5% Dec 31, 2018 10-K 2020-03-03
Q3 2018 119M +40.3M +51.4% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 116M +39.7M +51.9% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 91M +40.1M +78.9% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 82.9M +32M +62.9% Dec 31, 2017 8-K 2019-06-17
Q3 2017 78.5M +20.9M +36.4% Sep 30, 2017 10-Q/A 2018-02-27
Q2 2017 76.5M +11.1M +16.9% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 50.9M +12.5M +32.6% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 50.9M +13.1M +34.7% Dec 31, 2016 10-K 2018-03-16
Q3 2016 57.6M +19.8M +52.5% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 65.4M +29.1M +79.8% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 38.4M +2.12M +5.86% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 37.8M +1.59M +4.39% Dec 31, 2015 10-K/A 2017-03-27
Q3 2015 37.8M +9.23M +32.4% Sep 30, 2015 10-Q 2015-11-16
Q2 2015 36.4M +7.86M +27.5% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 36.3M +13.2M +57.3% Mar 31, 2015 10-Q 2015-05-05
Q4 2014 36.2M +13.2M +57.1% Dec 31, 2014 10-K 2016-03-15
Q3 2014 28.5M +12.1M +73.1% Sep 30, 2014 10-Q 2014-11-04
Q2 2014 28.5M +15.1M +112% Jun 30, 2014 10-Q 2014-08-06
Q1 2014 23.1M -313M -93.1% Mar 31, 2014 10-Q 2014-05-14
Q4 2013 23M +11M +91.8% Dec 31, 2013 10-K 2015-03-16
Q3 2013 16.5M -283M -94.5% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 13.4M -286M -95.5% Jun 30, 2013 10-Q 2013-08-13
Q1 2013 336M +73.7M +28.1% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 12M -250M -95.4% Dec 31, 2012 10-K 2014-04-01
Q3 2012 300M +50.1M +20% Sep 30, 2012 10-Q 2012-11-08
Q2 2012 300M +50.1M +20% Jun 30, 2012 10-Q 2012-08-14
Q1 2012 262M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 262M +11.5M +4.6% Dec 31, 2011 10-K/A 2013-03-27
Q3 2011 250M Sep 30, 2011 10-Q 2011-11-08
Q2 2011 250M Jun 30, 2011 10-Q 2011-08-12
Q4 2010 251M Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.